MedPath

To observe the effect of massage combined with milli-fire needle on myofascitis of the back region based on infrared thermography technology

Phase 1
Recruiting
Conditions
myofascitis
Registration Number
ITMCTR2000004200
Lead Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) The observation subjects were outpatient patients in the department of massage in The First Affiliated Hospital of Guangzhou University of Chinese Medicine.
2) It conforms to the diagnostic criteria of myofascitis of the back region in the Diagnostic and Therapeutic Criteria of Diseases and Syndromes of Traditional Chinese Medicine.
3) Patients aged between 20 and 65 years.
4) VASv < points.
5) The patient was sane, understandable, well compliant, voluntarily accepted this therapy, agreed to participate in this clinical study and signed informed consent surgeons.

Exclusion Criteria

1) There are localized skin infections at the treatment site.
2) Suffering from serious heart, lung, liver and kidney diseases.
3) Diabetes, hemophilia, thrombocytopenic purpura or severe osteoporosis.
4) Pregnancy or lactation.
5) Rheumatism, osteoarthrosis, tumor and fracture, etc.
6) Patients with abnormal coagulation function, skin damage or infection at tendon junction are not suitable for milli-fire needle.
7) In the last 2 weeks, take non-steroidal anti-inflammatory drugs, muscle relaxants, or acupuncture and massage, etc.
8) Patients who are currently participating in or have participated in other clinical trials in the month prior to this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale;Short Form 36 Health Survey Questionnaire (SF-36);Oswestry Disability Index (ODI);
Secondary Outcome Measures
NameTimeMethod
infrared thermography;
© Copyright 2025. All Rights Reserved by MedPath